Dominant point mutations in KBTBD13 cause nemaline myopathy 6 (NEM6), which is clinically characterized by weakness and slow muscle relaxation (Sambuughin et al., 2010). This evidence concerns the gene KBTBD13 and nemaline myopathy 6.